Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How do you know it’s 7M ? You people are insane. GC is con artist and he belongs in jail. He hidden everything, he never disclosed what the balance of convertible debt. If the company is making money why continue with toxic financing. He also mentioned cash flow positive by December and continues to borrow money through convertible debt.
Lol you are clueless. You are missing the point. I’m talking about GC he should be fired because he has done terrible job and you are talking about my average. Lol my average is lower than your .0489.
WTF! Are you kidding me. Since he became a CEO 1 year ago the outstanding shares increased by 380M. The stock should be traded $1 instead the SP is below .05.
I don’t like JP but he has valid point. The focus should be on GC job performance and not on JP. He has done terrible job and he needs to go period.
Lol wtf why keep talking about WOGI. Lol you probably one those fools that thinks GC has done good job.
You are comparing apples with oranges. If the company making money why would GC borrow more money through toxic financing. You probably voted that GC has done good job.
Come on Joe, GC is master of Twitter. I think the social media is the perfect way to get the attention.
49% is controlled by David and management.
He is worth over billion
Billionaire David Davidovich backed the merger. He is the largest shareholder of CBLI.
Interesting blurb from S-4
Because the market price of Cleveland BioLabs common stock is subject to fluctuation, the market value of the shares of Cleveland BioLabs common stock that Cytocom stockholders will be entitled to receive in the merger may increase or decrease.
As described in the accompanying proxy statement/prospectus, certain Cleveland BioLabs stockholders who in the aggregate owned approximately 48.9% of the outstanding shares of Cleveland BioLabs as of December 31, 2020 are parties to stockholder agreements with Cleveland BioLabs, whereby such stockholders have agreed to vote in favor of the approval of the issuance of Cleveland BioLabs common stock in the merger pursuant to the Merger Agreement.
The proxy will be filed in March and according to S-4, 49% already supported the merger
Yes, I reviewed the entire S-4, cyto have roughly 700K, and CBLI have almost 3M. They need 50m to complete the phase 3 trial. That’s why they raised 14M
They are so many trials mentioned on S-4. Merck just acquired early stage Autoimmune company for 1.85B, the most advanced asset is in phase 1. Massive risk for mrk to acquired Pandion
Honestly, after the merger we will see a lot of activities multiple phase 3 trials and ph 2 Covid 19 study that will start in 2 QTR. I personally think the valuation will skyrocket
26.6m shares *5.7= $151M roughly
The RS will not happened. In February 17 CYTO was valued around $344M. Also Cytocom will own 66% of the total post-merger. It seems it was increased from 61% to 66%
Thank you sharing.
CALCULATION OF REGISTRATION FEE
Title of each class of securities
to be registered
? ?
Amount to be
registered(1)
? ?
Proposed maximum
offering price
per share
? ?
Proposed maximum
aggregate
offering price(2)
? ?
Amount of
registration fee(3)
Common stock, par value $0.005 per share
? ?
26,640,000
? ?
N/A
? ?
$12,976
? ?
$2.00
S-4 link first page
http://archive.fast-edgar.com/20210216/AI228G2CZ2229ZDA222G2Z42MQJ9SC22Z232/
wtf I guess you are new on pennies stocks.
It was listed on S-4 form
Thanks. CYTO will get around 26.64M shares which are fixed no split and IMUN probably will receive around 3-3.4m shares after the merger
have good weekend.
Yes, because they are not doing RS after the merger. Usually Reverse merger after completion they do reverse stock split in order to up list.
Cyto current valuation: 26.64M *5.45 SP =145M
Depends on stock price but current valuation is roughly $144m for cyto
No split. CYTO Will receive roughly 26.64M shares
IMUN will own roughly 3.4-3.5M shares of combined companies.
You are crazy. Dilution? 470M OS. I guess your are newbie
Lol the company has not filed financial statements with SEC eg 10K or 10Q
That not true. FYI all conversion happened below .20 & you will see a lot shares been dumped at very low price.
If it was legit they could have raised money through public offerings. Let assume 100M shares @.30=30m could have been raised if it was legit company
Lol okay, you will see. Good luck with 2B shares outstanding and $860M MCAP. The stock price is irrelevant and valuation is very important.
Lol the SP is going down below.05
Amazing the outstanding shares increased by 250M in day. The current Outstanding Shares
1.945B
26,640,000 X stock price $10.50 =280M
IMUN probably will receive 3-4m shares after the merger
They are issuing 26,640,000 shares to Cytocom
Cytocom valuation is 340M as per s4 filing.
IMUN equity stake on cytocom is $51M and current market cap is $11M